Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
$0.11
$0.10
$0.08
$11.50
N/AN/AN/A867,698 shs
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
C$0.25
-2.0%
C$0.29
C$0.25
C$0.48
C$27.70M0.7258,205 shs42,000 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
0.00%0.00%0.00%0.00%0.00%
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
0.00%-15.52%-16.95%-25.76%-43.68%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
N/AN/AN/AN/AN/AN/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
0.00
N/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
N/AN/AN/AN/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
C$39.47M0.70C$0.03 per share8.93C$0.21 per share1.17
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
N/AN/A0.00N/AN/AN/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
-C$12.93M-C$0.12N/AN/A-32.75%-38.02%-7.55%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
N/AN/AN/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
N/AN/AN/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
71.72
1.42
1.11

Institutional Ownership

CompanyInstitutional Ownership
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
N/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
0.03%

Insider Ownership

CompanyInsider Ownership
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
N/A
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
3.95%
CompanyEmployeesShares OutstandingFree FloatOptionable
MOTIF BIO PLC/S stock logo
MTFB
MOTIF BIO PLC/S
7N/AN/ANot Optionable
Nanalysis Scientific Corp. stock logo
NSCI
Nanalysis Scientific
249113.06 millionN/ANot Optionable

Recent News About These Companies

Nanalysis Announces First Quarter 2025 Conference Call
Nanalysis Announces Release of Automation Software
Nanalysis Provides Fourth Quarter Preview (Unaudited)

Media Sentiment Over Time

MOTIF BIO PLC/S stock logo

MOTIF BIO PLC/S NASDAQ:MTFB

Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York.

Nanalysis Scientific stock logo

Nanalysis Scientific CVE:NSCI

C$0.24 -0.01 (-2.00%)
As of 05/30/2025 01:02 PM Eastern

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries. The company is headquartered in Calgary, Canada.